Language of the Report – English
Sin embargo, el informe puede estar disponible en español por un costo adicional.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Market Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 United States
6.2 By Region
7 Industry Opportunities and Challenges
8 COVID-19 Impact and Assessment
9 United States Medical Cannabis Market Analysis
9.1 Key Industry Highlights
9.2 United States Medical Cannabis Historical Market (2019-2025)
9.3 United States Medical Cannabis Market Forecast (2026-2035)
9.4 United States Medical Cannabis Market by Species
9.4.1 Indica
9.4.1.1 Market Share
9.4.1.2 Historical Trend (2019-2025)
9.4.1.3 Forecast Trend (2026-2035)
9.4.2 Sativa
9.4.2.1 Market Share
9.4.2.2 Historical Trend (2019-2025)
9.4.2.3 Forecast Trend (2026-2035)
9.4.3 Hybrid
9.4.3.1 Market Share
9.4.3.2 Historical Trend (2019-2025)
9.4.3.3 Forecast Trend (2026-2035)
9.5 United States Medical Cannabis Market by Derivative
9.5.1 Cannabidiol (CBD)
9.5.1.1 Market Share
9.5.1.2 Historical Trend (2019-2025)
9.5.1.3 Forecast Trend (2026-2035)
9.5.2 Tetrahydrocannabinol (THC)
9.5.2.1 Market Share
9.5.2.2 Historical Trend (2019-2025)
9.5.2.3 Forecast Trend (2026-2035)
9.6 United States Medical Cannabis Market by Route of Administration
9.6.1 Oral Solutions and Capsules
9.6.1.1 Market Share
9.6.1.2 Historical Trend (2019-2025)
9.6.1.3 Forecast Trend (2026-2035)
9.6.2 Smoking
9.6.2.1 Market Share
9.6.2.2 Historical Trend (2019-2025)
9.6.2.3 Forecast Trend (2026-2035)
9.6.3 Vaporizers
9.6.3.1 Market Share
9.6.3.2 Historical Trend (2019-2025)
9.6.3.3 Forecast Trend (2026-2035)
9.6.4 Topicals
9.6.4.1 Market Share
9.6.4.2 Historical Trend (2019-2025)
9.6.4.3 Forecast Trend (2026-2035)
9.6.5 Others
9.7 United States Medical Cannabis Market by Application
9.7.1 Cancer
9.7.1.1 Market Share
9.7.1.2 Historical Trend (2019-2025)
9.7.1.3 Forecast Trend (2026-2035)
9.7.2 Arthritis
9.7.2.1 Market Share
9.7.2.2 Historical Trend (2019-2025)
9.7.2.3 Forecast Trend (2026-2035)
9.7.3 Migraine
9.7.3.1 Market Share
9.7.3.2 Historical Trend (2019-2025)
9.7.3.3 Forecast Trend (2026-2035)
9.7.4 Epilepsy
9.7.4.1 Market Share
9.7.4.2 Historical Trend (2019-2025)
9.7.4.3 Forecast Trend (2026-2035)
9.7.5 Others
9.8 United States Medical Cannabis Market by End Use
9.8.1 Pharmaceutical Industry
9.8.1.1 Market Share
9.8.1.2 Historical Trend (2019-2025)
9.8.1.3 Forecast Trend (2026-2035)
9.8.2 Research and Development Center
9.8.2.1 Market Share
9.8.2.2 Historical Trend (2019-2025)
9.8.2.3 Forecast Trend (2026-2035)
9.8.3 Others
9.9 United States Medical Cannabis Market by Region
8.7.1 Market Share
9.9.1.1 New England
9.9.1.2 Mideast
9.9.1.3 Great Lakes
9.9.1.4 Plains
9.9.1.5 Southeast
9.9.1.6 Southwest
9.9.1.7 Rocky Mountain
9.9.1.8 Far West
10 Regional Analysis
10.1 New England
10.1.1 Historical Trend (2019-2025)
10.1.2 Forecast Trend (2026-2035)
10.2 Mideast
10.2.1 Historical Trend (2019-2025)
10.2.2 Forecast Trend (2026-2035)
10.3 Great Lakes
10.3.1 Historical Trend (2019-2025)
10.3.2 Forecast Trend (2026-2035)
10.4 Plains
10.4.1 Historical Trend (2019-2025)
10.4.2 Forecast Trend (2026-2035)
10.5 Southeast
10.5.1 Historical Trend (2019-2025)
10.5.2 Forecast Trend (2026-2035)
10.6 Southwest
10.6.1 Historical Trend (2019-2025)
10.6.2 Forecast Trend (2026-2035)
10.7 Rocky Mountain
10.7.1 Historical Trend (2019-2025)
10.7.2 Forecast Trend (2026-2035)
10.8 Far West
10.8.1 Historical Trend (2019-2025)
10.8.2 Forecast Trend (2026-2035)
11 Market Dynamics
11.1 SWOT Analysis
11.1.1 Strengths
11.1.2 Weaknesses
11.1.3 Opportunities
11.1.4 Threats
11.2 Porter’s Five Forces Analysis
11.2.1 Supplier’s Power
11.2.2 Buyers Powers
11.2.3 Threat of New Entrants
11.2.4 Degree of Rivalry
11.2.5 Threat of Substitutes
11.3 Key Indicators for Demand
11.4 Key Indicators for Price
12 Value Chain Analysis
13 Competitive Landscape
13.1 Market Structure
13.2 Key Players Market Share
13.3 Key Company Profiles
13.3.1 Tilray
13.3.1.1 Company Overview
13.3.1.2 Product Portfolio
13.3.1.3 Demographic Reach and Achievements
13.3.1.4 Certifications
13.3.2 Bedrocan International
13.3.2.1 Company Overview
13.3.2.2 Product Portfolio
13.3.2.3 Demographic Reach and Achievements
13.3.2.4 Certifications
13.3.3 Medical Marijuana, Inc.
13.3.3.1 Company Overview
13.3.3.2 Product Portfolio
13.3.3.3 Demographic Reach and Achievements
13.3.3.4 Certifications
13.3.4 United Cannabis
13.3.4.1 Company Overview
13.3.4.2 Product Portfolio
13.3.4.3 Demographic Reach and Achievements
13.3.4.4 Certifications
13.3.5 Cannabis Sativa Inc.
13.3.5.1 Company Overview
13.3.5.2 Product Portfolio
13.3.5.3 Demographic Reach and Achievements
13.3.5.4 Certifications
13.3.6 Canopy Growth Corporation
13.3.6.1 Company Overview
13.3.6.2 Product Portfolio
13.3.6.3 Demographic Reach and Achievements
13.3.6.4 Certifications
13.3.7 Aurora Cannabis Inc.
13.3.7.1 Company Overview
13.3.7.2 Product Portfolio
13.3.7.3 Demographic Reach and Achievements
13.3.7.4 Certifications
13.3.8 Vivo Cannabis Inc.
13.3.8.1 Company Overview
13.3.8.2 Product Portfolio
13.3.8.3 Demographic Reach and Achievements
13.3.8.4 Certifications
13.3.9 Others
14 Industry Events and Developments